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S U M M A R Y
Objectives: Acinetobacter baumannii can be responsible for community-acquired infections in tropical
climates like that of Reunion Island. The epidemiology of these community-acquired A. baumannii
infections is not well understood. The aim of this study was to characterize A. baumannii strains isolated
from patients at the time of admission to the university hospital of Saint-Denis, from environmental
samples, and from pets.
Methods: In this exploratory study, samples were collected by swabbing the rectum and mouth. A.
baumannii isolates from positive samples were identiﬁed by VITEK 2 system, blaOXA-51-like gene PCR, and
partial sequencing of the rpoB gene. Antimicrobial susceptibility testing was then performed. Strains
were further analysed by multilocus sequence typing and pulsed-ﬁeld gel electrophoresis.
Results: A high prevalence of A. baumannii carriage was found in pets (8.5%). Only one A. baumannii
isolate was resistant to carbapenems (isolated from a patient). A wide variety of A. baumannii, assigned to
different sequence types, were isolated from pets, humans, and the environment.
Conclusions: This study shows that A. baumannii strains are present outside the hospital setting in
Reunion Island and show great diversity. Further studies are needed to explore these extra-hospital
reservoirs of A. baumannii in Reunion Island in greater detail and to determine their possible means of
dissemination.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Acinetobacter baumannii is a ubiquitous microorganism. This
opportunistic pathogen is responsible for nosocomial infections in
immunocompromised and critically ill patients and for hospital
outbreaks, mainly in intensive care units (ICUs).1,2 A. baumannii is
often the cause of pneumonia in ventilated patients, urinary tract
infections in patients with urinary catheters, surgical wound
infections, and bacteraemia. In this context, multidrug-resistant
A. baumannii (MDR-AB) has become an international threat, with the
predominance and dissemination worldwide of MDR-AB clonal
lineages.3 An increasing prevalence of MDR-AB has been observed* Corresponding author. Tel.: +33 2 41 35 50 13; fax: +33 2 41 35 41 64.
E-mail address: MaEveillard@chu-angers.fr (M. Eveillard).
http://dx.doi.org/10.1016/j.ijid.2015.05.012
1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).in ICUs and also among older adults in community hospitals and
nursing homes.4 Furthermore, A. baumannii is a cause of communi-
ty-acquired infections, particularly pneumonia, and more rarely
bacteraemia, cellulitis, and meningitis.5 These infections often occur
either in zones of military conﬂict,6 or in the context of natural
disasters such as earthquakes and tsunamis,7,8 or in tropical and
subtropical areas.9,10Whereas the hospital ecology of this bacterium
in the context of outbreaks is well studied, the epidemiology of
A. baumannii outside of the outbreak context remains unclear.
The presence of A. baumannii in companion animals has been
documented recently. This microorganism has most often been
described as an agent of nosocomial infection in animals. Since the
beginning of the 2000s, A. baumannii strains have been isolated from
vascular catheters in horses hospitalized in an equine clinic, with or
without signs of vascular infection.11 Similarly, a Swiss studyciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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ICU, with the presence of strains in the hospital environment.12 In
another study conducted in Switzerland, A. baumannii isolates were
collected from infected surgical wounds and other types of infection
in animals hospitalized in a veterinary teaching hospital, conﬁrming
A. baumannii to be a nosocomial pathogen in veterinary medicine.13
More recently, studies have shown infections due to A. baumannii at
various body sites in hospitalized animals.14,15Most of these studies
have been performed on hospitalized animals and have explored the
involvement of A. baumannii in nosocomial infection. However, few
data exist concerning the colonization of pets by A. baumannii, and
only a few publications have shown the importance of animals as
a reservoir of A. baumannii for transmission.16,17
Furthermore, some publications have shown the presence of
A. baumannii in environmental samples out of the hospital.
A. baumannii strains have been recovered from vegetables,18 from
environments of human habitation like tables in parks and games
consoles,19 and from soil.20,21
The aims of the present exploratory study were to gain a better
understanding of the epidemiology of A. baumannii outside of
the hospital outbreak context and to describe the diversity of the
A. baumannii isolated from pets and humans.
2. Materials and methods
2.1. Sample collection
To determine the prevalence of animal A. baumannii carriers, a
study was conducted at 14 veterinary clinics located all over the
island of La Re´union (Figure 1). Over a period of 7 days, both a rectal
and an oral swab were collected from all cats and dogs brought
for consultation or hospitalization in these veterinary clinics.
Overall, 141 pets were sampled. A standardized questionnaire wasFigure 1. Geographical distribution of the veterinary clinics (VC) and of the samples p
veterinary clinics in the town/number of pets sampled/number of positive samples) and
isolated strains.completed for each animal to obtain information such as the type
of animal, its age, living in a household with other animals, the
type of visit to the veterinarian (hospitalization or outpatient visit),
the length of stay in the veterinary clinic at the time of sampling,
the reason for the hospitalization or outpatient visit, the presence
of an invasive device, surgery in the previous month or in the
previous year in the case of material implantation, antibiotherapy
within the last 15 days, and the presence of symptoms of infection.
Similarly, human carriage of A. baumannii was studied in
patients admitted to the University Hospital of Saint-Denis. Over
the course of 6 months, all patients with an A. baumannii-positive
sample identiﬁed within the ﬁrst 48 h of hospitalization in a
clinical sample or in a carriage screening sample were included in
this study. A standardized questionnaire was completed for each
patient with a positive A. baumannii sample to collect information
such as the age of the patient, the date of and the reason for
hospitalization, the clinical ward in which the patient was
hospitalized, the type of sample (clinical or a carriage screening
sample), underlying diseases, antimicrobial treatments within the
30 days preceding the date of hospitalization, the type of housing
(urban, rural), the presence of pets or a kitchen garden at home,
and the presence of agricultural land, animal breeding, slurry, ﬁsh-
farming, a sewage plant, or hydrocarbons in the neighbourhood.
When A. baumannii was present in a clinical sample and associated
with clinical signs of infection, this was deﬁned as an infection
case. In the other cases, it was deﬁned as carriage.
Finally, the prevalence of A. baumannii in environmental
samples was studied. Sixty-nine soil and sludge samples were
taken from different biotopes all over La Re´union: 17 samples were
obtained from ditches on the roadside, 15 near isolated houses,
13 from sugar cane ﬁelds, seven from gardens and parks, six from
ponds, three from cattle farms, three from gas stations, two from a
forest, two from rivers, and one from a picnic area.ositive for Acinetobacter baumannii from animals (circles: number of participating
 from the environment (stars: number of positive samples); sequence types of the
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The swabs were inoculated on three agar media: (1) UTI
chromogenic agar medium (UTI, Oxoid, Basingstoke, UK), (2) ESBL
agar medium (bioMe´rieux, Marcy l’Etoile, France), a medium
selective for Gram-negative bacilli resistant to third-generation
cephalosporins, and (3) CHROMagar Acinetobacter medium
(CHROMagar, Paris, France), a medium selective for Acinetobacter
spp. Each microorganism growing on the plates and showing
Gram-negative staining and an oxidase-negative test was then
selected for identiﬁcation.
2.3. Bacterial identiﬁcation
Identiﬁcations were performed with the VITEK 2 system
(bioMe´rieux, Marcy l’Etoile, France). Each strain identiﬁed as
‘A. baumannii complex’ was subjected to PCR for the determination
of blaOXA-51-like genes
22 and partial sequencing of the rpoB gene23
to identify A. baumannii.
2.4. Antimicrobial susceptibility testing
Antimicrobial susceptibility testing was done by disk
diffusion method, in accordance with the joint recommenda-
tions of the Antibiogram Committee of the French Society for
Microbiology (CA-SFM) and the European Committee on
Antimicrobial Susceptibility Testing (EUCAST) (http://www.
sfm-microbiologie.org/UserFiles/ﬁles/casfm/CASFM_EUCAST_
V1_0_2014.pdf).
2.5. Identiﬁcation of carbapenemase-encoding genes
When an A. baumannii isolate was resistant to carbapenems
(two isolates in this study), real-time PCR assays to detect blaOXA-
23, blaOXA-24, blaOXA-58, and blaNDM
24 were performed to determine
the presence of carbapenemase-encoding genes.
2.6. Multilocus sequence typing (MLST)
Genotyping analysis was performed by MLST, as described
previously.25 MLST was done as per the Pasteur scheme (http://
pubmlst.org/abaumannii/). The new sequence types (STs) have
been assigned by MLST Pasteur.Table 1
Characteristics of patients from whom Acinetobacter baumannii (AB) was isolated
AB isolate Patient area of
residence
Patient origin Number of days between
admission and sample
PASCh Sainte-Clotilde Reunion Island 2 
RATEm Sainte-Clotilde Madagascar 0 
BREJe Sainte-Clotilde Reunion Island 2 
BOMMa Saint-Benoıˆt Reunion Island 2 
ALIMo Sainte-Clotilde Madagascar 1 
PAYCl Saint-Paul Reunion Island 2 
BAPTe Le Port Reunion Island 0 
BAIWi Sainte-Clotilde Reunion Island 2 
IFAGe Saint-Denis Reunion Island 1 
HUBSt Sainte-Clotilde Metropolitan France 0 
HEDDa Saint-Benoıˆt Reunion Island 2 
DECRa Saint-Denis Reunion Island 0 
ALLMo Saint-Denis Mayotte 0 
RODEm Sainte-Clotilde Reunion Island 0 
TOUAn Saint-Denis Reunion Island 2 
VELCl Sainte-Clotilde Reunion Island 2 
TOPMa Saint-Andre´ Reunion Island 0 
SEPJe Saint-Denis Reunion Island 2 
RASTa Sainte-Clotilde Madagascar 2 
MADFat Saint-Denis Mayotte 2 2.7. Pulsed-ﬁeld gel electrophoresis (PFGE)
Strains assigned to the same ST were then typed by PFGE
analysis of ApaI-digested genomic DNA, as described previously.26
The isolates were classiﬁed into PFGE types according to the
criteria of Tenover et al.27
2.8. Statistical analysis
A descriptive analysis of the patients identiﬁed as A. baumannii
carriers was performed. The prevalence of A. baumannii carriage
in pets was calculated, along with the 95% conﬁdence interval
(95% CI). A comparison of the characteristics of A. baumannii
carriers and non-carriers was performed for pets by univariate
analysis (Chi-square test or Fisher’s exact test, as appropriate).
Associations were characterized by the odds ratio (OR).
3. Results
3.1. Animals and humans sampled
Of the 141 animals sampled, 102 were dogs and 39 were cats.
Most of the animals sampled in this study were brought to the clinic
for a consultation and were not hospitalized (n = 100, 70.9%). Of the
remaining 41 animals that were hospitalized, 28 (68.3%) had been
hospitalized for less than 1 day at the time of sample collection.
Among the animals sampled, 60.3% were living in a community with
other animals. There was a signiﬁcant association between the
presence of an invasive device and the carriage of A. baumannii (OR
4.14, p < 0.05). No signiﬁcant association was found between
carriage of A. baumannii and being treated with antibiotics on the
day of the survey. There was an association between A. baumannii
carriage and treatment with antibiotics within the 15 days preceding
the sample (OR 2.70), but this was not signiﬁcant (p = 0.14).
Of the 20 patients identiﬁed as A. baumannii carriers within the
48 h following hospital admission, 11 were female and nine were
male, and the average age was 38 years (range 5–78 years). Of
these, six were pet owners and three had received antimicrobial
therapy within the 15 days before hospital admission. Eleven
patients had been hospitalized within the preceding 6 months, four
had diabetes mellitus, two lived near a cattle breeding facility, and
six came from outside of Reunion Island (Mayotte, Madagascar,
and Metropolitan France) (Table 1).Reason for
admission
Positive sample Carriage or
infection
AB sequence
type
Meningitis Rectal swab, screening Carriage ST582
Re-education Wound Carriage ST132
Epilepsy Rectal swab, screening Carriage ST584
Cardiogenic shock Rectal swab, screening Carriage ST360
Hepatitis A Rectal swab, screening Carriage ST126
Burn injury Wound Carriage ST107
Sternotomy pain Rectal swab, screening Carriage ST406
Dermabrasion Wound Carriage ST585
Poisoning Rectal swab, screening Carriage ST107
Pharyngitis Tonsil sample Infection ST33
Psychiatry Rectal swab, screening Carriage ST107
Epilepsy Rectal swab, screening Carriage ST107
Epilepsy Rectal swab, screening Carriage ST336
Burn injury Wound Carriage ST477
Anaemia Wound Carriage ST2
Surgery Catheter oriﬁce Carriage ST107
Respiratory distress Rectal swab, screening Carriage ST150
Gastroenteritis Wound Carriage ST253
Varicella Urine Carriage ST478
Childbirth Urine Carriage ST107
Table 2
Characteristics of companion animals from which Acinetobacter baumannii (AB) was isolated
Animal species Veterinary clinic
(VC) location
Consultation or
hospitalization
Day of
sample (D)
Length of
hospitalization
until the sample
Reason for
consultation
at the VC
Positive
sample
AB strain AB sequence
type
Dog Saint-Andre´ Hospitalization D8 1 day Convulsions Pharyngeal SAPG4 ST481
Cat Saint-Andre´ Hospitalization D8 1 day Anticoagulant poisoning Rectal NUTA4 ST103
Dog Saint-Leu Consultation D2 - Tiredness Rectal VENA7 ST2
Cat Saint-Gilles-les-Bains Consultation D2 - Abscess Pharyngeal GIUB1 ST203
Dog Sainte-Marie Hospitalization D3 1 day Gastroenteritis Pharyngeal BLAG11 ST2
Cat Ravine des Cabris Consultation D4 - Castration Pharyngeal GRIG2 ST2
Dog Ravine des Cabris Consultation D3 - Wound Pharyngeal FOXG2 ST586
Dog Ravine des Cabris Consultation D3 - Vaccination Pharyngeal ROMG2 ST2
Dog Ravine des Cabris Consultation D3 - Wound Rectal FISA2 ST581
Dog Saint-Leu Consultation D3 - Vaccination Pharyngeal SHAB7 ST2
Dog Saint-Denis Consultation D2 - Vaccination Rectal PHRA14 ST386
Dog Ravine des Cabris Consultation D3 - Abscess Rectal KITG2 ST164
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Of the 141 animals sampled, 12 were A. baumannii carriers
(prevalence 8.5%, 95% CI 4.0–13.0%). These strains harboured the
blaOXA-51-like genes and were identiﬁed as A. baumannii by rpoB
gene sequencing technique. These 12 A. baumannii carrier pets
were sampled at six different veterinary clinics (Table 2). The
localization of the veterinary clinics in which A. baumannii carrier
pets were identiﬁed is presented in Figure 1.
Of the 69 environmental samples obtained, two were positive
for A. baumannii. These strains were identiﬁed as A. baumannii by
blaOXA-51-like PCR and by rpoB gene sequencing technique. These two
A. baumannii strains were isolated from two different areas of
La Re´union: one near the city of Saint-Louis, in the southern area of
the island, and the other near Salazie, in the centre of the island
(Figure 1).
3.3. Antimicrobial susceptibility testing
The A. baumannii strains isolated from animals were further
tested for their resistance to antibiotics. Among the A. baumannii
isolated from pets, seven strains were susceptible to piperacillin,
piperacillin–tazobactam, ceftazidime, ticarcillin, ticarcillin–
clavulanic acid, carbapenems, aminoglycosides, colistin, trimeth-
oprim–sulfamethoxazole, doxycycline, oﬂoxacin, ciproﬂoxacin,
and norﬂoxacin. The ﬁve other strains were resistant toDice (O pt:0.25%) (T ol 1.0%-1 .0%) (H >0.0% S> 0.0%) [0.0%-1 00.0%]
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Figure 2. Pulsed-ﬁeld gel electrophoresis dendrogram of the Acinetobacter baumacephalosporins and were considered MDR according to the
classiﬁcation of Magiorakos et al.28
Of the 20 patient isolates, 18 were susceptible to piperacillin,
piperacillin–tazobactam, ceftazidime, ticarcillin, ticarcillin–clavu-
lanic acid, carbapenems, aminoglycosides, colistin, trimethoprim–
sulfamethoxazole, doxycycline, oﬂoxacin, ciproﬂoxacin, and nor-
ﬂoxacin. One isolate was resistant to cephalosporins and was
considered MDR according to Magiorakos et al.28 The remaining
strain was highly resistant, with resistance to imipenem and
meropenem, and was classiﬁed as extensively drug-resistant
according to Magiorakos et al.28 This strain carried the blaOXA-23-
like gene and was negative for the other carbapenem resistance
genes tested.
The two strains isolated from environmental samples were
susceptible to piperacillin, piperacillin–tazobactam, ceftazidime,
ticarcillin, ticarcillin–clavulanic acid, carbapenems, aminoglycosides,
colistin, trimethoprim–sulfamethoxazole, doxycycline, oﬂoxacin,
ciproﬂoxacin, and norﬂoxacin.
3.4. MLST
MLST analysis was performed on the 12 animal strains of A.
baumannii. These strains were assigned to eight different STs: ﬁve
isolates were assigned to ST2, one to ST164, one to ST386, one to
ST103, one to ST203, one to ST481, one to ST581, and one to ST586.
These three last STs have not been described previously.Gri Gueule 2
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isolated from patients. These strains were assigned to 15 different
STs: 10 STs have already been described (ST2, ST33, ST107 (six
isolates), ST126, ST132, ST150, ST253, ST336, ST360, and ST406)
and ﬁve STs have not been described previously (ST477, ST478,
ST582, ST584, and ST585).
The two A. baumannii strains isolated from the environment
were analysed by MLST. These two strains were assigned to two
different STs, the ﬁrst to ST1 and the second to a novel ST, ST583.
3.5. PFGE
PFGE analysis was performed on the ﬁve A. baumannii isolated
from pets and belonging to ST2. The ﬁve isolates were closely
related (>90% similarity) (Figure 2). The geographical distribution
of the different STs of the A. baumannii isolated in pets is shown in
Figure 1. The ﬁve ST2 A. baumannii strains that belonged to the
same cluster on PFGE analysis were isolated from three different
veterinary clinics: one was isolated in Sainte-Marie, two were
isolated in Ravine des Cabris (from samples obtained on two
different days), and two were isolated in Saint-Leu (from samples
obtained on two different days).
The six isolates assigned to ST107 were then compared by PFGE
analysis. Four of them were not related (clusters C, E, F, and G) and
two were closely related (>90% similarity, cluster D) (Figure 2).
These two strains were isolated from two patients colonized by A.
baumannii living in different cities (Saint-Denis and Sainte-
Clotilde), who had been hospitalized 6 months apart in two
different clinical wards.
Furthermore, the isolates assigned to ST2 were compared by
PFGE analysis to the animal strains belonging to the same ST. This
patient strain (cluster B) was different from the cluster A proﬁle of
the animal isolates (Figure 2).
4. Discussion
A prevalence of A. baumannii carriage of 8.5% was found in pets.
This result is quite similar to that of a previous study performed on
138 animals, which showed a prevalence of A. baumannii in pets of
6.5%.16 In most previous studies, A. baumannii strains in companion
animals have been isolated in the context of hospitalized animals
and likely nosocomial acquisition.12–15 In the present study,
among the 12 animals that were identiﬁed to be positive for A.
baumannii carriage, nine were not hospitalized at the time of
sample collection (outpatient visits) and the other three had been
hospitalized for less than 1 day. Thus, the A. baumannii carriage in
these animals was most probably linked with a contamination
outside of the veterinary clinics. These data conﬁrm the high
prevalence of A. baumannii in pets in Reunion Island outside the
context of nosocomial acquisition and hospitalization.
Little is known of the characteristics of A. baumannii strains isolated
from animal carriage unrelated to the outbreak situation. In this
study, a notable variety of STs isolated from animals was observed,
with the description of three new STs. Furthermore, ﬁve isolates were
assigned to ST2. It is noteworthy that ST2 A. baumannii have recently
been reported as responsible for human infections due to carbape-
nem-resistant A. baumannii in different continents (Algeria, Yemen,
Italy, and Japan).29–32Most of these infections were hospital-acquired
and were involved in outbreaks. In the present study, no A. baumannii
assigned to ST2 was carbapenem-resistant.
The results of this study differ from those of a previous study
conducted in companion animals in Reunion Island. Indeed, in
the previous study most of the A. baumannii strains isolated were
assigned to ST25. The two studies were performed using the same
microbiological methods and by the same investigators. The only
noticeable difference is that the ﬁrst study was performed at theend of the cold and dry season, whereas the present study was
conducted at the end of the hot and wet season (the difference
in temperature between the two seasons varies from 5 to 10 8C).
One hypothesis could be that the climate may have inﬂuenced the
variety of A. baumannii isolated from pets, maybe because of the
existence of different environmental reservoirs. Indeed, for many
infectious agents, non-human reservoir species and pathogen
replication rates are particularly sensitive to climatic condi-
tions.33,34 Numerous theories have been developed in recent years
to explain the relationships between climate change and infectious
diseases, including higher proliferation and reproduction rates at
higher temperatures and changes in reservoir hosts.35 However, it
is noteworthy that in the two studies, some closely-related isolates
were identiﬁed in pets from different areas of Reunion Island. The
existence of these communities of strains identiﬁed in the two
studies suggests that some A. baumannii strains may have become
dispersed through the island via vectors such as arthropods and
other mammalians (stray dogs, cattle). It has been demonstrated
that community-acquired A. baumannii infections occur most often
during the warmest and wettest seasons in inter-tropical areas.36
These data are in accordance with the results of a time-series
analysis reported in a study conducted at the University of
Maryland Medical Center, which demonstrated that the increase in
monthly A. baumannii infection rate was 17% for each 10 8C
increase in outdoor temperature.37 This strongly marked seasonal
distribution could be related to certain climatic or environmental
features involved in the acquisition of these bacteria by patients.38
Another hypothesis is the existence of environmental reservoirs.
During the last decade, several studies have reported the identiﬁca-
tion of A. baumannii in various environmental locations. It has been
recovered from soil contaminated with petroleum hydrocarbons in
India and in France,39,40 from vegetables collected in supermarkets,
greengrocers, and private gardens,18 from manured agricultural soil
and pig slurry in the UK,41 and from aquaculture environments in
Southeast Asia.42 In this study, two of 69 samples of soil and sludge
recovered in Reunion Island were positive for A. baumannii isolates.
These two strains were assigned to ST1 and ST583 respectively.
These two STs were not found in the A. baumannii strains isolated
in animals or in patients. ST583 is a new MLST and is a singleton with
no link to any clonal complex. Conversely, the other A. baumannii
isolated from an environment sample was assigned to ST1, an ST
belonging to clone CC1, which is a widespread international
clone among the nosocomial MDR A. baumannii.3,43,44
Concurrently, in the 20 strains isolated from patients, 15 STs
were identiﬁed, including ﬁve new STs. Only two isolates were
closely related. One was isolated from a patient from Saint-Paul
and the other was isolated from a patient from Saint-Denis. These
results are consistent with those of other studies that have
described an important diversity of A. baumannii strains in
community-acquired infections.9,45 Data on the involvement of
A. baumannii belonging to ST107 in community- and hospital-
acquired infections appear to be limited. It is noteworthy that
almost a third of A. baumannii carriers had been hospitalized
within the preceding 6 months. Therefore, they could have
acquired their A. baumannii during a previous hospital stay. In
addition, it could be argued that the A. baumannii were isolated
from hospitalized patients. However, they had been sampled
within the 48 h following admission, and it was only possible to
obtain screening samples in the hospital setting.
This exploratory study was not designed to identify the means
of transmission of A. baumannii between humans, animals, and the
environment. The objective was to describe the dissemination and
the diversity of these bacteria on Reunion Island. Further studies
including pets, their owners, and their environment are needed to
explore the hypothesis of transmission. The household transmis-
sion of methicillin-resistant Staphylococcus aureus has been
H. Pailhorie`s et al. / International Journal of Infectious Diseases 37 (2015) 64–69 69presented as a model of the interaction between humans, animals,
and the environment.46 It would be interesting to investigate the
potential household transmission of A. baumannii. Similarly, it
would also be interesting to search for A. baumannii on breeding
farms among cattle, pastures, and farmers. Finally, it is planned to
include hospital-acquired A. baumannii in a future comparison.
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